New England Biolabs (NEB) has entered into agreement with Rubicon Genomics to distribute its Single Cell Whole Genome Amplification (WGA) Kit that uses Rubicon's proprietary amplification technology.

Rubicon’s amplification technology enables the amplification of DNA from single cells or extremely low amounts of input DNA.

The Single Cell WGA Kit is expected to find use in numerous research applications, including cancer studies.

Rubicon president and CEO Jim Koziarz said they look forward to working with NEB to leverage their early successes in the diagnostic market into the research market.

"The single cell amplification technology has already been widely adopted in the in vitro fertilization (IVF) market, and we are excited at the prospects this product has in research applications," Koziarz said.